To further define the role of SNORD3A and verify its correlation with the newly identified upstream regulator and downstream effectors in breast cancer clinical samples, we first examined SNORD3A and miR-185-5p levels via ISH in breast cancer tissues (N = 72). This evidence concerns the gene SNORD3A and breast cancer.